Friday, July 10, 2026

Drug profile · INN

vinflunine

vinflunine (JAVLOR) is a tubulin inhibitor.

EMA: approved Antineoplastic and immunomodulating agents (L01) L01CA05
Patents linked 0
Pipeline programs 8
News articles 0
Drug details — vinflunine
Class
Antineoplastic and immunomodulating agents (L01)
Route
Patents
0
Programs
8
Data quality
0.83

Quick answer

vinflunine (JAVLOR) is a tubulin inhibitor.

Key facts

INN vinflunine
Brand JAVLOR
Mechanism Tubulin inhibitor
Target Tubulin
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01CA05

Mechanism of action

Tubulin inhibitor

Primary target: Tubulin

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. 42756493BLC3001 Phase 3 · Janssen-Cilag International N.V · Advanced Urothelial Cancer
  2. 7465-CL-0301 Phase 3 · Astellas Pharma · Locally advanced or metastatic urothelial cancer
  3. IMMU-132-13 Phase 3 · Gilead Sciences · Locally Advanced or Metastatic Unresectable Urothelial Cance
  4. MK-2870-031 Phase 3 · MSD Merck Sharp · Locally advanced/metastatic urothelial carcinoma
  5. Vinflunine Phase 3 · Bristol Myers Squibb · Stomach Cancer
  6. vinflunine Phase 3 · Pierre Fabre Medicament · Breast Cancer
  7. Vinflunine Phase 2 · United Therapeutics Europe · Locally-advanced or Metastatic Penile Neoplasms
  8. vinflunine Phase 2 · Bristol Myers Squibb · Transitional Cell Carcinoma

Related & competitor drugs

  1. abiraterone acetate Antineoplastic and immunomodulating agents (L02)
  2. anagrelide Antineoplastic and immunomodulating agents (L01)
  3. apremilast Antineoplastic and immunomodulating agents (L04)
  4. arsenic trioxide Antineoplastic and immunomodulating agents (L01)
  5. axitinib Antineoplastic and immunomodulating agents (L01)
  6. azacitidine Antineoplastic and immunomodulating agents (L01)

Frequently asked questions

What is vinflunine?

vinflunine (JAVLOR) is a tubulin inhibitor.

What is the brand name for vinflunine?

JAVLOR is a marketed brand name for vinflunine. Check FDA Drugs@FDA for the current US label holder and prescribing information.